Home / Markets / URGN / Balance Sheet ← All companies U UroGen Pharma Ltd. URGN - CIK 0001668243
Overview Market Cap Revenue Net Income Income Statement Balance Sheet Cash Flow SEC Filings URGN balance sheet (quarterly) The table below shows UroGen Pharma Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item Q1 2026 Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Cash & equivalents $109.97M $90.04M $92.90M $104.03M $124.92M $219.97M Short-term investments $39.74M $63.79M $83.11M $112.03M $153.93M $52.28M Receivables $55.41M $19.70M $19.65M $19.64M $22.80M $17.41M Inventory $20.92M $8.34M $7.13M $7.59M $7.59M $7.44M
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings .